Denying Inappropriate PCSK9 Prescriptions Keeps Costs In Check For Express Scripts
This article was originally published in The Pink Sheet Daily
Executive Summary
About 50% of the scripts being written for the cholesterol-lowering drugs are being denied, Chief Trade Relations Officer Everett Neville indicated during the Pharmaceutical Strategy Conference.